Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01726842 · ClinicalTrials.gov registry record
Amblyopia and Strabismus Detection Using a Pediatric Vision Scanner
A clinical trial, sponsored by Rebiscan.
- Completed
- Registry status
- 300
- Enrollment target
NCT01726842: Completed study, sponsored by Rebiscan.
NCT01726842 is a clinical trial that has completed, run by Rebiscan. The registered enrollment target is 300 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01726842 has completed, sponsored by Rebiscan.
- COMPLETED
- Registry status
- 300 participants
- Enrollment target
Study Summary
The purpose of this project is to compare the performance of the Pediatric Vision Scanner (PVS) with the Gold Standard Examination to determine the effectiveness of the PVS at detecting amblyopia and strabismus.
Interventions
- DEVICE Pediatric Vision Scanner
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2010-10 |
| Est. Completion | 2012-12 |
What the finished NCT01726842 record still lists
NCT01726842 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Pediatric Vision Scanner is the first listed.
NCT01726842 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01726842 about?
NCT01726842 is a clinical study titled "Amblyopia and Strabismus Detection Using a Pediatric Vision Scanner". The purpose of this project is to compare the performance of the Pediatric Vision Scanner (PVS) with the Gold Standard Examination to determine the effectiveness of the PVS at detecting amblyopia and strabismus.
What is the current status of trial NCT01726842?
This trial is currently completed. The enrollment target is 300 participants. The study started on 2010-10. Estimated completion is 2012-12.
What interventions are being tested in trial NCT01726842?
The interventions under investigation include: Pediatric Vision Scanner (DEVICE).
Who is sponsoring clinical trial NCT01726842?
This trial is sponsored by Rebiscan, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia